|Articles|November 1, 2014
- BioPharm International-11-01-2014
- Volume 27
- Issue 11
BioPharm International, November 2014 Issue (PDF)
Click the title above to open the BioPharm International November 2014 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 11 years ago
Germany Post AMNOG: Insights for BioPharmaover 11 years ago
Standardizing Practices for Cellular Therapy Manufacturingover 11 years ago
Setting Standards for Biotech Therapeutics in Indiaover 11 years ago
Viral Clearance Challenges in Bioprocessingover 11 years ago
Outside Looking Inover 11 years ago
Cell Culture Consumables Prevent Contaminationover 11 years ago
Hype vs. Healthover 11 years ago
New Era for Generic Drugsover 11 years ago
DoE Provides Benefits, but Preparation Is NecessaryNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5
